ACR 2022 Tweet by Patricia Harkins

⬆️ serum anti-CCP3 Ab, absence IA
👉 StopRA trial - ironically stopped🛑

❌ hydroxychloroquine not superior to PBO in preventing/ delaying IA
👉rate of conversion to RA in CCP3+ve ~35% @ 3yrs

#ACR22 @RheumNow Abst#1604